Wednesday, February 10, 2010, 9:44pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Abaxis Inc. (ABAX)

At 5:00AM SGT: 23.23 USD   0.00 (0.00%)  
 MORE ON ABAX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ABAXIS, Inc. (NasdaqNM:ABAX) Delayed quote dataEdit
Last Trade:23.23 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:23.23
Open:N/A
Bid:21.88 x 100
Ask:24.54 x 100
1y Target Est:27.25
Day's Range:N/A - N/A
52wk Range:13.54 - 29.80
Volume:0
Avg Vol (3m):135,778
Market Cap:511.85M
P/E (ttm):40.33
EPS (ttm):0.58
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ABAX to Portfolio   Download Data

 HEADLINES 
•Abaxis Misses Zacks Estimate
Zacks.com (Mon, Feb 1)
•New Star Analyst Rankings for ABAXIS, Inc.
StarMine (Sat, Jan 30)
•[$$] Russell 2000 Closes Out January With a Decline of 1%
at The Wall Street Journal Online (Sat, Jan 30)
•ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Fri, Jan 29)
•Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010
PR Newswire (Fri, Jan 29)
•Abaxis to Report Third Quarter Fiscal 2010 Financial Results Thursday, January 28, 2010
PR Newswire (Thu, Jan 28)
•Q3 2010 Abaxis, Inc. Earnings Release - Time Not Supplied
CCBN (Thu, Jan 28)
•Abaxis Receives Approval
Zacks.com (Fri, Jan 22)
•Abaxis says FDA clears new infection test
AP (Fri, Jan 22)
•FDA clears Abaxis health-care testing product
at bizjournals.com (Thu, Jan 21)
•Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
PR Newswire (Thu, Jan 21)
•Abaxis to Report Third Quarter Fiscal 2010 Financial Results Thursday, January 28, 2010
PR Newswire (Thu, Jan 21)
More Headlines for ABAX...
 ANALYST 
EPS Est (next year) (Mar-10) :0.66
EPS Est (in 2 years) (Mar-11) :0.88
Avg Rec (current)*:2.5
PEG Ratio:1.75
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements in the medical and veterinarian markets...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices